BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

BioNews
Biotechnology, Pharmaceutical and Life Science News
search help

Search Results

Documents 1-10 out of 10 found
  Current Search:  systemic: 75, lupus: 70, erythematosus: 9     

HTML
100%
TopAbstracts in Viral Infections 01/05/2009
TopAbstracts in Viral Infections are the abstracts most highly rated/most read by nearly 300,000 physicians who received a Doctor's Guide newsletter or visited a website Powered by Doctor's Guide in the past 14 days.

Over 2000 peer...

Doctors Guide:  Jan 6 2009 10:13PM
Matching: systemic lupus erythematosus
Find similar documents
HTML
100%
Research and Markets: Systemic Lupus Erythematosus Imprecise Segmentation Complicates Treatment Algorithms
Lupus is a chronic, autoimmune disorder, characterized by unpredictable flares and remissions.

Affected areas can include the joints, skin, kidneys, heart, lungs, blood vessels and the brain.

There are currently only three...

Pharma Live:  Dec 19 2008 12:41PM
Matching: systemic lupus erythematosus
Find similar documents
HTML
100%
Clinical Characteristics and Outcomes of the Meningitides in Systemic Lupus Erythematosus
Baizabal-Carvallo JF et al.

- Meningitis was observed in about 1.6% of the patients with SLE; in 40% of the cases, no microorganism could be isolated.

A residual neurological deficit was more common in patients with septic meningitis.

MDLinx:  Dec 19 2008 9:48AM
Matching: systemic lupus erythematosus
Find similar documents
HTML
61%
Angiotensin-converting enzyme gene does not contribute to genetic susceptibility to systemic sclerosis in Euro
systemic sclerosis;angiotensin-converting enzyme gene Email Password Remember me HomeGeneral Topics in Pediatric For Practicing Rheumatologists D Scott Cunningham MD, PhD, MDLinx Today's News: D Scott Cunningham MD, PhD, MDLinx Article...
MDLinx:  Dec 18 2008 11:03AM
Matching: systemic lupus
Find similar documents
HTML
100%
Findings from National Institutes of Health in lupus reported
- (NewsRx.com) -- 'For the development of rabbit models of Systemic Lupus Erythematosus (SLE), immunoglobulin allotype-defined pedigreed rabbits from the National Institute of Allergy and Infectious Diseases rabbit resource...
Therapeutics Daily:  Dec 11 2008 8:33PM
Matching: systemic lupus erythematosus
Find similar documents
HTML
100%
Cephalon and ImmuPharma Sign a $15 million Option Agreement for Late- Stage Experimental Lupus Medication
Cephalon, Inc.and ImmuPharma PLC has announced that the companies have signed an Option Agreement providing Cephalon with an option to obtain an exclusive, worldwide license to the investigational medication Lupuzor for the treatment of ...
CombiChemnet:  Nov 30 2008 7:38AM
Matching: systemic lupus erythematosus
Find similar documents
HTML
100%
Cephalon & Immupharma Sign
FRAZER, PA.

and LONDON - Cephalon Inc.

and ImmuPharma PLC, a European pharmaceutical company, announced that the companies have signed an Option Agreement providing Cephalon with an option to obtain an exclusive, worldwide license to the...

Intellectual Property News Agency:  Nov 30 2008 12:25PM
Matching: systemic lupus erythematosus
Find similar documents
HTML
100%
Cephalon, ImmuPharma sign $15 mn pact for late- stage experimental Lupus medication
Cephalon, Inc and ImmuPharma PLC, a European pharmaceutical company, announced that the companies have signed an Option Agreement providing Cephalon with an option to obtain an exclusive, worldwide license to the investigational medication...
PharmaBiz:  Nov 27 2008 10:57AM
Matching: systemic lupus erythematosus
Find similar documents
HTML
100%
Cephalon and ImmuPharma Sign a $15 million Option Agreement for Late- Stage Experimental Lupus Medication
/PRNewswire-FirstCall/ -- Cephalon, Inc.

and ImmuPharma PLC , a European pharmaceutical company, today announced that the companies have signed an Option Agreement providing Cephalon with an option to obtain an exclusive, worldwide license...

Pharma Live:  Nov 25 2008 2:16PM
Matching: systemic lupus erythematosus
Find similar documents
HTML
100%
Active Biotech Presents New Data regarding the 57-57 SLE Project at American College of Rheumatology Meeting
LUND, Sweden, Oct.

28, 2008-Active Biotech (NASDAQ OMX Nordic: ACTI) has presented data regarding the 57-57 project at the American College of Rheumatology (ACR) Annual Scientific Meeting, a premier event for specialists in the field of...

Pharma Live:  Oct 28 2008 4:48PM
Matching: systemic lupus erythematosus
Find similar documents


 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.